Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment.
Saved in:
| Title: | Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment. |
|---|---|
| Authors: | Winters N; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada., Schnitzer ME; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada.; Faculty of Pharmacy, Université de Montréal, Montreal, Canada.; Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada., Campbell JR; Department of Medicine & Department of Global and Public Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.; McGill International TB Centre, Montreal Chest Institute, Research Institute of the McGill University Health Centre, Montreal, Canada.; Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada., Ripley S; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada., Winston C; US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Savic R; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco Schools of Pharmacy and Medicine, San Francisco, California, United States of America.; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America., Ahmad N; Faculty of Pharmacy and Health Sciences, University of Baluchistan, Quetta, Pakistan., Bisson G; Department of Medicine and Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America., Dheda K; Centre for Lung Infection and Immunity, Department of Medicine & UCT Lung Institute, University of Cape Town, Cape Town, South Africa., Esmail A; Centre for Lung Infection and Immunity, Department of Medicine & UCT Lung Institute, University of Cape Town, Cape Town, South Africa., Gegia M; Global Tuberculosis Program, World Health Organization, Geneva, Switzerland., Monedero I; TB-HIV Department, International Union against Tuberculosis and Lung Diseases, Paris, France., Dalcolmo MP; Centro de Referência Helio Fraga, Fiocruz, Brazil., Rodrigues D; Instituto Clemente Ferreira, Sao Paulo, Brazil., Singla R; National Institute of Tuberculosis & Respiratory Diseases, New Delhi, India., Yim JJ; Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Seoul National University College of Medicine, Seoul, South Korea., Menzies D; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada.; McGill International TB Centre, Montreal Chest Institute, Research Institute of the McGill University Health Centre, Montreal, Canada. |
| Source: | PloS one [PLoS One] 2023 Oct 05; Vol. 18 (10), pp. e0292106. Date of Electronic Publication: 2023 Oct 05 (Print Publication: 2023). |
| Publication Type: | Meta-Analysis; Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0292106 |
